2021


  1. Knoll T, Halbritter J (2021). 'Case of the Month' from the University Medicine Mannheim: managing a complex stone patient with recurrent stone formation. BJU Int, 127, 402-408.
     
  2. Halbritter J (2021). Genetics of kidney stone disease-Polygenic meets monogenic. Nephrol Ther, 17, 88-94.
     
  3. Münch J, Krüger BM, Weimann A, Wiech T, Reinhard L, Hoxha E, Pfister F, Halbritter J (2021). Posttransplant nephrotic syndrome resulting from NELL1-positive membranous nephropathy. Am J Transplant, 21, 3175-3179.
     
  4. de Fallois J, Schönauer R, Münch J, Nagel M, Popp B, Halbritter J (2021). Challenging Disease Ontology by Instances of Atypical PKHD1 and PKD1 Genetics. Front Genet, 12, 1-8.
     
  5. Servais A, Thomas K, Dello Strologo L, Sayer JA, Bekri S, Bertholet-Thomas A, Bultitude M, Capolongo G, Cerkauskiene R, Daudon M, Doizi S, Gillion V, Gràcia-Garcia S, Halbritter J, Heidet L, van den Heijkant M, Lemoine S, Knebelmann B, Emma F, Levtchenko E (2021). Cystinuria: clinical practice recommendation. Kidney Int, 99, 48-58.
     
  6. Servais A, Thomas K, Dello Strologo L, Sayer JA, Bekri S, Bertholet-Thomas A, Bultitude M, Capolongo G, Cerkauskiene R, Daudon M, Doizi S, Gillion V, Gràcia-Garcia S, Halbritter J, Heidet L, van den Heijkant M, Lemoine S, Knebelmann B, Emma F, Levtchenko E (2021). Cystinuria: clinical practice recommendation. Kidney Int, 99, 48-58.
     


  7. 2020


  8. Tönjes A, Hoffmann A, Kralisch S, Qureshi AR, Klöting N, Scholz M, Schleinitz D, Bachmann A, Kratzsch J, Nowicki M, Paeschke S, Wirkner K, Enzenbach C, Baber R, Beige J, Anders M, Bast I, Blüher M, Kovacs P, Löffler M, Zhang MZ, Harris RC, Stenvinkel P, Stumvoll M, Fasshauer M, Ebert T (2020). Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease. Eur J Endocrinol, 183, 233-244.
     
  9. Schönauer R, Baatz S, Nemitz-Kliemchen M, Frank V, Petzold F, Sewerin S, Popp B, Münch J, Neuber S, Bergmann C, Halbritter J (2020). Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes. Genet Med, 22, 1374-1383.
     
  10. Krasselt M, Halbritter J, Amann K, Baerwald C, Seifert O (2020). ANCA-positive IgA nephropathy in a patient with ANA-positive long-standing rheumatoid arthritis and type 1 diabetes. Clin Exp Rheumatol, 38 , 241-242.
     
  11. Schönauer R, Jin W, Ertel A, Nemitz-Kliemchen M, Panitz N, Hantmann E, Seidel A, Braun DA, Shril S, Hansen M, Shahzad K, Sandford R, Saunier S, Benmerah A, Bergmann C, Hildebrandt F, Halbritter J (2020). Novel nephronophthisis-associated variants reveal functional importance of MAPKBP1 dimerization for centriolar recruitment. Kidney Int, 98, 958-969.
     
  12. Münch J, Kirschner KM, Schlee H, Kraus C, Schönauer R, Jin W, Le Duc D, Scholz H, Halbritter J (2020). Autosomal dominant polycystic kidney disease in absence of renal cyst formation illustrates genetic interaction between WT1 and PKD1. J Med Genet, 0, 1-5.
     
  13. Bayraktar S, Nehrig J, Menis E, Karli K, Janning A, Struk T, Halbritter J, Michgehl U, Krahn MP, Schuberth CE, Pavenstädt H, Wedlich-Söldner R (2020). A Deregulated Stress Response Underlies Distinct INF2-Associated Disease Profiles. J Am Soc Nephrol, 31, 1296-1313.
     
  14. Bayraktar S, Nehrig J, Menis E, Karli K, Janning A, Struk T, Halbritter J, Michgehl U, Krahn MP, Schuberth CE, Pavenstädt H, Wedlich-Söldner R (2020). A Deregulated Stress Response Underlies Distinct INF2-Associated Disease Profiles. J Am Soc Nephrol, 31, 1296-1313.
     


  15. 2019


  16. Ottlewski I, Munch J, Wagner T, Schonauer R, Bachmann A, Weimann A, Hentschel J, Lindner TH, Seehofer D, Bergmann C, Jamra RA, Halbritter J (2019). Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int, 96, 222-230.
     
  17. Petzold F, Bachmann A, Bergmann C, Helmchen U, Halbritter J (2019). Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation. BMC Nephrol, 20, 340-345.
     
  18. Trawinski H, Karlas T, Seehofer D, Lubbert C, Halbritter J (2019). The Case | Atypical cysts in a patient with autosomal dominant polycystic kidney disease. Kidney Int, 96, 1043-1044.
     
  19. Schonauer R, Petzold F, Lucinescu W, Seidel A, Muller L, Neuber S, Bergmann C, Sayer JA, Werner A, Halbritter J (2019). Evaluating pathogenicity of SLC34A3-Ser192Leu, a frequent European missense variant in disorders of renal phosphate wasting. Urolithiasis, 47, 511-519.
     
  20. Schonauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J (2019). Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome. Front Genet, 10, 465-471.
     
  21. Amar A, Majmundar AJ, Ullah I, Afzal A, Braun DA, Shril S, Daga A, Jobst-Schwan T, Ahmad M, Sayer JA, Gee HY, Halbritter J, Knopfel T, Hernando N, Werner A, Wagner C, Khaliq S, Hildebrandt F (2019). Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet, 138, 211-219.
     
  22. Choi YJ, Halbritter J, Braun DA, Schueler M, Schapiro D, Rim JH, Nandadasa S, Choi WI, Widmeier E, Shril S, Korber F, Sethi SK, Lifton RP, Beck BB, Apte SS, Gee HY, Hildebrandt F (2019). Mutations of ADAMTS9 Cause Nephronophthisis-Related Ciliopathy. Am J Hum Genet, 104, 45-54.
     
  23. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sorensen SS, Dauber EM, Bohmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R (2019). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 19, 475-487.
     
  24. Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Gorg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, Konig IR, Kurschat C, Lehmann C, Marget M, Muhlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Susal C, Thiele B, Zecher D, Lachmann N (2019). Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin J Am Soc Nephrol, 14, 1056-1066.
     


  25. 2018


  26. Halbritter J, Seidel A, Muller L, Schonauer R, Hoppe B (2018). Update on Hereditary Kidney Stone Disease and Introduction of a New Clinical Patient Registry in Germany. Front Pediatr, 6, 47.
     
  27. Rasche FM, Joel C, Ebert T, Frese T, Barinka F, Busch V, Rasche WG, Lindner TH, Schneider J, Schiekofer S (2018). Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease. Exp Clin Endocrinol Diabetes, 126(1), 39-52.
     
  28. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126(6), 349-356.
     
  29. Schmalz G, Dietl M, Vasko R, Muller GA, Rothermund L, Keller F, Ziebolz D, Rasche FM (2018). Dialysis vintage time has the strongest correlation to psychosocial pattern of oral health-related quality of life - a multicentre cross-sectional study. Med Oral Patol Oral Cir Bucal, 23, 698-706.
     
  30. Seidel A, Müller L, Schönauer R, Halbritter J (2018). Genetik und Mechanismen der Nierensteinbildung ? neu geschaffenes Register für hereditäre Nierensteinleiden und Nephrokalzinose. Nieren- und Hochdruckkrankheiten, 9, 464-471.
     
  31. Daga A, Majmundar AJ, Braun DA, Gee HY, Lawson JA, Shril S, Jobst-Schwan T, Vivante A, Schapiro D, Tan W, Warejko JK, Widmeier E, Nelson CP, Fathy HM, Gucev Z, Soliman NA, Hashmi S, Halbritter J, Halt (2018). Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int, 93(1), 204-213.
     
  32. Fahnert J, Stumpp P, Kahn T, Keller F, Schiekofer S, Petros S, Halbritter J, Lindner TH, Rasche FM (2018). Early Flow Disturbances of Tunnelled Haemodialysis Catheters and Topographic Landmarks in Chest X-Ray. Blood Purif, 46, 70-76.
     
  33. Knaup KX, Hackenbeck T, Popp B, Stoeckert J, Wenzel A, Buttner-Herold M, Pfister F, Schueler M, Seven D, May AM, Halbritter J, Grone HJ, Reis A, Beck BB, Amann K, Ekici AB, Wiesener MS (2018). Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition. J Am Soc Nephrol, 29, 2298-2309.
     
  34. Fearn A, Allison B, Rice SJ, Edwards N, Halbritter J, Bourgeois S, Pastor-Arroyo EM, Hildebrandt F, Tasic V, Wagner CA, Hernando N, Sayer JA, Werner A (2018). Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations. Physiol Rep, 6, 13715-13722.
     
  35. Rasche FM, Joel C, Ebert T, Frese T, Barinka F, Busch V, Rasche WG, Lindner TH, Schneider J, Schiekofer S (2018). Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease. Exp Clin Endocrinol Diabetes, 126, 39-52.
     
  36. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126, 349-356.
     
  37. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126, 349-356.
     
  38. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Meding (2018). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 13, 1-13.
     
  39. Hoff S, Epting D, Falk N, Schroda S, Braun DA, Halbritter J, Hildebrandt F, Kramer-Zucker A, Bergmann C, Walz G, Lienkamp SS (2018). The nucleoside-diphosphate kinase NME3 associates with nephronophthisis proteins and is required for ciliary function during renal development. J Biol Chem, 293, 15243-15255.
     
  40. Paschke L, Lincke T, Muhlberg KS, Jabs WJ, Lindner TH, Paschke R (2018). Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials. Eur Thyroid J, 7, 308-312.
     


  41. 2017


  42. Krasselt M, Pierer M, Amann K, Bachmann A, Lindner TH (2017). [Clinical Course of an Early Childhood-Onset Granulomatosis with Polyangiitis]. Dtsch Med Wochenschr, 142(12), 904-908.
     
  43. Rasche FM, Ebert T, Beckmann J, Busch V, Barinka F, Rasche WG, Lindner TH, Schneider JG, Schiekofer S (2017). Influence of Erythropoiesis-Stimulating Agents on HbA1c and Fructosamine in Patients with Haemodialysis. Exp Clin Endocrinol Diabetes, 125(6), 384-391.
     
  44. Rasche FM, Stoebe S, Ebert T, Feige S, Hagendorff A, Rasche WG, Barinka F, Busch V, Sack U, Schneider JG, Schiekofer S (2017). Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients. BMC Nephrol, 18(1), 175.
     
  45. Sedaghat S, Heshmati ES, Frese T, Rasche WG, Barinka F, Fahr F, Beige J, Schiekofer S, Rasche FM (2017). Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany?. Clin Nephrol, 88(12), 317-327.
     
  46. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). FSTL3 is increased in renal dysfunction. Nephrol Dial Transplant, 32(10), 1637-1644.
     
  47. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. Diabetes Metab, 43(5), 465-468.
     
  48. Munch J, Bachmann A, Grohmann M, Mayer C, Kirschfink M, Lindner TH, Bergmann C, Halbritter J (2017). Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies. Clin Kidney J, 10(6), 742-746.
     
  49. Macia MS, Halbritter J, Delous M, Bredrup C, Gutter A, Filhol E, Mellgren AE, Leh S, Bizet A, Braun DA, Gee HY, Silbermann F, Henry C, Krug P, Bole-Feysot C, Nitschke P, Joly D, Nicoud P, Paget A, Hau (2017). Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. Am J Hum Genet, 100(2), 323-333.
     
  50. Macia MS, Halbritter J, Delous M, Bredrup C, Gutter A, Filhol E, Mellgren AE, Leh S, Bizet A, Braun DA, Gee HY, Silbermann F, Henry C, Krug P, Bole-Feysot C, Nitschke P, Joly D, Nicoud P, Paget A, Hau (2017). Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. Correction. Am J Hum Genet, 100(2), 372.
     
  51. Schiekofer S, Kleber ME, Maerz W, Rasche FM, Schneider JG (2017). The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo. Int J Endocrinol, 2017, 2869090.
     


  52. 2016


  53. Anders R, Grohmann M, Lindner TH, Bergmann C, Halbritter J (2016). [Hemolytic kidney failure and transient ischemic attack in a 32-year-old female]. Internist (Berl), 57(10), 1022-1028.
     
  54. Munch J, Grohmann M, Lindner TH, Bergmann C, Halbritter J (2016). Diagnosing FSGS without kidney biopsy - a novel INF2-mutation in a family with ESRD of unknown origin. BMC Med Genet, 17(1), 73.
     
  55. Rasche FM, Keller F, Rasche WG, Schiekofer S, Kahn T, Fahnert J (2016). Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up. Clin Exp Immunol, 183(2), 307-316.
     
  56. Rasche FM, Keller F, Rasche WG, Schiekofer S, Boldt A, Sack U, Fahnert J (2016). Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? Clin Exp Immunol, 186(2), 115-133.
     
  57. Zschiedrich S, Budde K, Nurnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hoerl WH, Obermuller N, Arns W, Pavenstadt H, Gaedeke J, Lindner TH, Faerber L, Wimmer P, Stork R, Eckardt KU, Walz G (2016). Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant, 31(2), 284-289.
     
  58. Miernik A, Hein S, Adams F, Halbritter J, Schoenthaler M (2016). [Stone treatment tomorrow and the day after]. Urologe A, 55(10), 1309-1316.
     
  59. Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F (2016). Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet, 98(6), 1228-1234.
     
  60. Dieckow J, Rasche W, Sterker I, Schob S, Rasche FM, Wiedemann P (2016). [A 70-year-old patient with painful exophthalmos and double vision]. Ophthalmologe, 113(1), 78-80.
     


  61. 2015


  62. Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F (2015). Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol, 26(3), 543-551.
     
  63. Rasche FM, Schmidt S, Kretzschmar C, Mertens M, Thiel J, Groschup MH, Schlegel M, Mayer C, Lindner TH, Schiekofer S, Ulrich RG (2015). Autochthonous Dobrava-Belgrade virus infection in Eastern Germany. Clin Nephrol, 83(2), 111-116.
     
  64. Schueler M, Braun DA, Chandrasekar G, Gee HY, Klasson TD, Halbritter J, Bieder A, Porath JD, Airik R, Zhou W, LoTurco JJ, Che A, Otto EA, Bockenhauer D, Sebire NJ, Honzik T, Harris PC, Koon SJ, Gunay- (2015). DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling. Am J Hum Genet, 96(1), 81-92.
     
  65. Hilger AC, Halbritter J, Pennimpede T, van der Ven A, Sarma G, Braun DA, Porath JD, Kohl S, Hwang DY, Dworschak GC, Hermann BG, Pavlova A, El-Maarri O, Nothen MM, Ludwig M, Reutter H, Hildebrandt F (2015). Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association. Hum Mutat, 36(12), 1150-1154.
     
  66. Perrault I, Halbritter J, Porath JD, Gerard X, Braun DA, Gee HY, Fathy HM, Saunier S, Cormier-Daire V, Thomas S, Attie-Bitach T, Boddaert N, Taschner M, Schueler M, Lorentzen E, Lifton RP, Lawson JA, (2015). IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy phenotype. J Med Genet, 52(10), 657-665.
     
  67. Roberson EC, Dowdle WE, Ozanturk A, Garcia-Gonzalo FR, Li C, Halbritter J, Elkhartoufi N, Porath JD, Cope H, Ashley-Koch A, Gregory S, Thomas S, Sayer JA, Saunier S, Otto EA, Katsanis N, Davis EE, Att (2015). TMEM231, mutated in orofaciodigital and Meckel syndromes, organizes the ciliary transition zone. J Cell Biol, 209(1), 129-142.
     
  68. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker (2015). A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol, 26(6), 1279-1289.
     
  69. Berger T, Kaiser T, Scholz M, Bachmann A, Ceglarek U, Hesse G, Hagemeyer B, Stumvoll M, Thiery J, Dietz A (2015). Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL). Eur Arch Otorhinolaryngol, 272(12), 3693-3703.
     
  70. Karlas T, Berger J, Garnov N, Lindner F, Busse H, Linder N, Schaudinn A, Relke B, Chakaroun R, Troltzsch M, Wiegand J, Keim V (2015). Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. World J Gastroenterol, 21(16), 4894-4902.
     


  71. 2014


  72. Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Bast I, Anders M, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol, 170(4), 501-506.
     
  73. Hindricks J, Ebert T, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf), 80(6), 918-924.
     
  74. Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lossner U, Platz M, Kratzsch J, Stolzenburg JU, Dietel A, Grisk O, Beige J, Anders M, Bast I, Kloting N, Bluher M, Stumvoll M, Fasshauer M (2014). Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction. Nutr Metab Cardiovasc Dis, 24(9), 1027-1034.
     
  75. Ebert T, Kralisch S, Hoffmann A, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Tonjes A, Fasshauer M (2014). Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab, 99(12), 2510-2517.
     
  76. Hau HM, Tautenhahn HM, Schmelzle M, Krenzien F, Schoenberg MB, Morgul MH, Uhlmann D, Wiltberger G, Rasche M, Bachmann A, Jonas S, Bartels M (2014). Management of urologic complications in renal transplantation: a single-center experience. Transplant Proc, 46(5), 1332-1339.
     
  77. Boldt A, Kahlenberg F, Fricke S, Rasche FM, Sack U (2014). Flow cytometric phenotyping of lymphocytes in patients with systemic lupus erythematosus. Cytometry A, 85(7), 567-569.
     


  78. 2013


  79. Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of the adipokine progranulin depend on renal function. Diabetes Care, 36(2), 410-414.
     
  80. Lindner TH (2013). Diabetische Nephropathie. Einführung. Diabetologe, 9(8), 611-612.
     
  81. Lindner TH (2013). Proteinurie und Blocker des Renin-Angiotensin-Aldosteron-Systems. Diabetologe, 9(8), 622-630.
     
  82. Rebala K, Martinez-Cruz B, Tonjes A, Kovacs P, Stumvoll M, Lindner I, Buttner A, Wichmann HE, Sivakova D, Sotak M, Quintana-Murci L, Szczerkowska Z, Comas D (2013). Contemporary paternal genetic landscape of Polish and German populations: from early medieval Slavic expansion to post-World War II resettlements. Eur J Hum Genet, 21(4), 415-422.
     
  83. Keller M, Schleinitz D, Forster J, Tonjes A, Bottcher Y, Fischer-Rosinsky A, Breitfeld J, Weidle K, Rayner NW, Burkhardt R, Enigk B, Muller I, Halbritter J, Koriath M, Pfeiffer A, Krohn K, Groop L, Sp (2013). THOC5: a novel gene involved in HDL-cholesterol metabolism. J Lipid Res, 54(11), 3170-3176.
     
  84. Ponisch W, Moll B, Bourgeois M, Andrea M, Schliwa T, Heyn S, Schmalfeld M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Egert M, Stiegler R, Krahl R, Remane Y, Bachmann A, Lindner T, We (2013). Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure. J Cancer Res Clin Oncol, 139(11), 1937-1946.
     
  85. Arelin M, Schulze B, Muller-Myhsok B, Horn D, Diers A, Uhlenberg B, Nurnberg P, Nurnberg G, Becker C, Mundlos S, Lindner TH, Sperling K, Hoffmann K (2013). Genome-wide linkage analysis is a powerful prenatal diagnostic tool in families with unknown genetic defects. Eur J Hum Genet, 21(4), 367-372.
     


  86. 2012


  87. Halbritter J, Wittenburg H, Schiefke I, Amann K, Lindner T, Rasche FM (2012). MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis. Inflamm Bowel Dis, 18(3), 599-600.
     
  88. Ponisch W, Andrea M, Wagner I, Hammerschmidt D, Kreibich U, Schwarzer A, Zehrfeld T, Schwarz M, Winkelmann C, Petros S, Bachmann A, Lindner T, Niederwieser D (2012). Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone. J Cancer Res Clin Oncol, 138(8), 1405-1412.
     


  89. 2011


  90. Baranowski T, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine fasting-induced adipose factor/angiopoietin-like protein 4 depend on renal function. Horm Metab Res, 43(2), 117-120.
     
  91. Schleinitz D, Kloting N, Bottcher Y, Wolf S, Dietrich K, Tonjes A, Breitfeld J, Enigk B, Halbritter J, Korner A, Schon MR, Jenkner J, Tseng YH, Lohmann T, Dressler M, Stumvoll M, Bluher M, Kovacs P (2011). Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity. PLoS One, 6(2), e16155.
     
  92. Philipp A, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism, 60(5), 669-672.
     
  93. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     
  94. Enigk U, Breitfeld J, Schleinitz D, Dietrich K, Halbritter J, Fischer-Rosinsky A, Enigk B, Muller I, Spranger J, Pfeiffer A, Stumvoll M, Kovacs P, Tonjes A (2011). Role of genetic variation in the human sodium-glucose cotransporter 2 gene (SGLT2) in glucose homeostasis. Pharmacogenomics, 12(8), 1119-1126.
     
  95. Halbritter J, Mayer C, Bachmann A, Rasche FM, Uhlmann D, Stumvoll M, Lindner TH (2011). Successful simultaneous pancreas kidney transplantation in maturity-onset diabetes of the young type 5. Transplantation, 92(8), 45-47.
     
  96. Dietrich K, Birkmeier S, Schleinitz D, Breitfeld J, Enigk B, Muller I, Bottcher Y, Lindner T, Stumvoll M, Tonjes A, Kovacs P (2011). Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany. Diabet Med, 28(11), 1373-1380.
     
  97. Tonjes A, Wittenburg H, Halbritter J, Renner O, Harsch S, Stange EF, Lammert F, Stumvoll M, Kovacs P (2011). Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts. BMC Med Genet, 12, e149.
     
  98. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     
  99. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation, 124(8), 940-950.
     


  100. 2010


  101. Reiche M, Bachmann A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters. Horm Metab Res, 42(3), 178-181.
     
  102. Pfau D, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care, 33(1), 171-173.
     
  103. Basara N, Rasche FM, Schwalenberg T, Wickenhauser C, Maier M, Ivovic J, Niederwieser D, Lindner TH (2010). Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis? J Transplant, 2010, e297358.
     
  104. Cirak S, von Deimling F, Sachdev S, Errington WJ, Herrmann R, Bonnemann C, Brockmann K, Hinderlich S, Lindner TH, Steinbrecher A, Hoffmann K, Prive GG, Hannink M, Nurnberg P, Voit T (2010). Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain, 133(7), 2123-2135.
     
  105. Weise A, Timmermann B, Grabherr M, Werber M, Heyn P, Kosyakova N, Liehr T, Neitzel H, Konrat K, Bommer C, Dietrich C, Rajab A, Reinhardt R, Mundlos S, Lindner TH, Hoffmann K (2010). High-throughput sequencing of microdissected chromosomal regions. Eur J Hum Genet, 18(4), 457-462.
     


  106. 2009


  107. Stein S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care, 32(1), 126-128.
     
  108. Ebert T, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism, 58(4), 547-551.
     
  109. Hoffmann K, Planitz C, Ruschendorf F, Muller-Myhsok B, Stassen HH, Lucke B, Mattheisen M, Stumvoll M, Bochmann R, Zschornack M, Wienker TF, Nurnberg P, Reis A, Luft FC, Lindner TH (2009). A novel locus for arterial hypertension on chromosome 1p36 maps to a metabolic syndrome trait cluster in the Sorbs, a Slavic population isolate in Germany. J Hypertens, 27(5), 983-990.
     
  110. Halbritter J, Mayer C, Rasche FM, Amann K, Lindner TH (2009). [Interstitial nephritis] Internist (Berl), 50(9), 1111-1125.
     
  111. Seifert W, Beninde J, Hoffmann K, Lindner TH, Bassir C, Aksu F, Hübner C, Verbeek NE, Mundlos S, Horn D (2009). HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing. Eur J Hum Genet, 17(12), 1570-1576.
     
  112. Huppertz A, Wildung D, Kemp BJ, Nentwig T, Asbach P, Rasche FM, Hamm B (2009). Nondestructive insights into composition of the sculpture of Egyptian Queen Nefertiti with CT. Radiology, 251(1), 233-240.
     
  113. Czock D, Rasche FM, Boesler B, Shipkova M, Keller F (2009). Irinotecan in cancer patients with end-stage renal failure. Ann Pharmacother, 43(2), 363-369.
     


  114. 2008


  115. Mayer C, Bottcher Y, Kovacs P, Halbritter J, Stumvoll M (2008). Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturity-onset diabetes of the young type 5 gene. Metabolism, 57(3), 416-420.
     
  116. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab, 93(1), 247-251.
     
  117. Mayer C, Muller A, Halbritter J, Wirtz H, Stumvoll M (2008). Isolated renal relapse of sarcoidosis under low-dose glucocorticoid therapy. J Gen Intern Med, 23(6), 879-882.
     
  118. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism, 57(10), 1414-1421.
     
  119. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf), 69(6), 901-905.
     
  120. Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis, 199(2), 440-444.
     
  121. Cantagrel V, Silhavy JL, Bielas SL, Swistun D, Marsh SE, Bertrand JY, Audollent S, Attie-Bitach T, Holden KR, Dobyns WB, Traver D, Al-Gazali L, Ali BR, Lindner TH, Caspary T, Otto EA, Hildebrandt F, G (2008). Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome. Am J Hum Genet, 83(2), 170-179.
     


  122. 2007


  123. Kreißig C, Bachmann A, Stumvoll M, Schröcke G (2007). PD Dr. med. habil. Harald Achenbach zum 65. Geburtstag Ärzteblatt Sachsen, 18(9), 480.
     
  124. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2007). Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care, 30(10), 2588-2592.
     


  125. 2006


  126. Hoffmeister A, Wittenburg H, Teich N, Bachmann A, Borte G, Mossner J, Achenbach H (2006). [A 32-year-old patient with diarrhoe and acute kidney failure.] Internist (Berl), 47(10), 1063-1067.
     


  127. 2004


  128. Thamer C, Haap M, Bachmann O, Zur Nieden T, Tschritter O, Stefan N, Fritsche A, Jacob S, Stumvoll M, Haring H (2004). Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia, 47(7), 1303-1305.
     
  129. Thamer C, Machann J, Haap M, Bachmann O, Wietek B, Dahl D, Tschritter O, Fritsche A, Jacob S, Schick F, Stumvoll M, Haring H (2004). [Reduced insulin effect in subclinical fatty liver] Dtsch Med Wochenschr, 129(16), 872-875.